BOOM-IBD2 Pivotal Clinical Trial

NARecruitingINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

October 31, 2026

Conditions
Ulcerative ColitisInflammatory Bowel Diseases
Interventions
DEVICE

Neuromodulation

Neuromodulation

Trial Locations (10)

10032

RECRUITING

Columbia University Irving Medical Center/New York Presbyterian Hospital, New York

63141

RECRUITING

Objective Health - St. Louis, St Louis

76712

RECRUITING

Objective Health - Central Texas, Waco

79106

RECRUITING

Objective Health - Amarillo, Amarillo

89113

RECRUITING

Las Vegas Medical Research LLC, DBA Vector Clinical Trials, Las Vegas

90048

RECRUITING

Center for Colorectal Innovation, Los Angeles

92663

RECRUITING

Hoag Hospital, Newport Beach

94301

RECRUITING

PAMF (Palo Alto Medical Foundation), Palo Alto

67226-8119

RECRUITING

Kansas Gastro, Wichita

27599-1350

RECRUITING

UNC Chapel Hill, Chapel Hill

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Boomerang Medical

INDUSTRY